Our aim is to create ecosystem to make India lead in drug discovery: PM

India has a large pool of scientists and technologists with a potential to take the industry to greater heights, says PM Modi at Global Innovation Summit of the Pharmaceuticals sector

modi
PM Narendra Modi
BS Web Team New Delhi
2 min read Last Updated : Nov 18 2021 | 5:51 PM IST
Prime Minister Narendra Modi on Thursday inaugurated the first Global Innovation Summit of the Pharmaceuticals sector and said the global trust earned by the Indian healthcare sector has led to India being called the “pharmacy of the world” in recent times.

Addressing the gathering, the Prime Minister said that the pandemic has brought the pharmaceuticals sector into sharp focus. Whether it is lifestyle, or medicines, or medical technology, or vaccines, every aspect of healthcare has received global attention over the last two years, he said. In this context, the Prime Minister said that the Indian pharmaceutical industry has also risen to the challenge. “The global trust earned by the Indian healthcare sector has led to India being called the “pharmacy of the world” in recent times," Modi added.

The Prime Minister elaborated that “our definition of wellness is not limited by physical boundaries. We believe in the well-being of the entire humankind. And, we have shown this spirit to the whole world during the Covid-19 global pandemic”. During the pandemic, “we exported lifesaving medicines and medical equipment to over 150 countries during the initial phase of the pandemic. We have also exported more than 65 million doses of Covid vaccines to nearly 100 countries this year”, The Prime Minister informed. .

The Prime Minister envisioned creating an ecosystem for innovation that will make India a leader in drug discovery and innovative medical devices. He said policy interventions are being made based on wide consultation with all stakeholders. The Prime Minister noted that India has a large pool of scientists and technologists with a potential to take the industry to greater heights. “This strength needs to be harnessed  to “Discover and Make in India," he added.

The Prime Minister stressed on developing indigenous capabilities. “Today, when 1.3 billion people of India have taken it upon themselves to make India Aatmanirbhar, we must think about ramping up domestic manufacturing of key ingredients for vaccines and medicines. This is one frontier that India has to conquer," the Prime Minister urged.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Narendra ModiPharma

Next Story